Cargando…
A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34(+) Cells
Upon functional loss of insulin producing islet β-cells, some patients with diabetes become dependent on life-long insulin supplementation therapy. Bioengineering surrogate insulin producing cells is an alternative replacement strategy. We have developed a novel approach using short-activating RNA o...
Autores principales: | Reebye, Vikash, Sætrom, Pål, Mintz, Paul J, Rossi, John J, Kasahara, Noriyuki, Nteliopoulos, Georgios, Nicholls, Joanna, Haoudi, Abdelali, Gordon, Myrtle, Habib, Nagy A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696904/ https://www.ncbi.nlm.nih.gov/pubmed/23736775 http://dx.doi.org/10.1038/mtna.2013.23 |
Ejemplares similares
-
Exploiting Human CD34(+) Stem Cell–conditioned Medium for Tissue Repair
por: Mintz, Paul J, et al.
Publicado: (2014) -
MicroRNA-181a* Targets Nanog in a Subpopulation of CD34(+) Cells Isolated From Peripheral Blood
por: Mintz, Paul J, et al.
Publicado: (2012) -
Loss of MafA and MafB expression promotes islet inflammation
por: Singh, Tania, et al.
Publicado: (2019) -
MafA Expression Preserves Immune Homeostasis in Human and Mouse Islets
por: Singh, Tania, et al.
Publicado: (2018) -
The MafA Transcription Factor Becomes Essential to Islet β-Cells Soon After Birth
por: Hang, Yan, et al.
Publicado: (2014)